Clinical Trial Update: Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of sarilumab in polymyalgia rheumatica has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: TERMINATED | Results posted: 2022-06-10